Article citationsMore>>

Akashi, Y., Okamoto, I., Iwasa, T., et al. (2008) Enhancement of the Antitumor Activity of Ionising Radiation by Nimotuzumab, a Humanised Monoclonal Antibody to the Epidermal Growth Factor Receptor, in Non-Small Cell Lung Cancer Cell Lines of Differing Epidermal Growth Factor Receptor Status. British Journal of Cancer, 98, 749-755. http://dx.doi.org/10.1038/sj.bjc.6604222

has been cited by the following article:

• TITLE: Nimotuzumab in Treatment of Infiltrating Squamous Cell Carcinoma of Tongue

  AUTHORS: Alex A. Prasad

  KEYWORDS: Nimotuzumab, Epidermal Growth Factor Receptor (EGFR), Transforming Growth Factor α (TGFα)

  JOURNAL NAME: Journal of Cancer Therapy, Vol.6 No.2, January 30, 2015

  ABSTRACT: A 50-year male patient presented to outpatient department with a mass on tongue associated with pain. A plain computerised tomography scan done on 17/01/13 revealed mild growth on lateral border of tongue with an enlarged jugulo-digastric lymph node measuring 1.8×1 cm. Excision of tongue was done and sent for histopathological examination which revealed infiltrating squamous cell carcinoma. The patient was treated with 2 cycles of Induction chemotherapy with cisplatin and paclitaxel administered in q3w schedule. Induction chemotherapy was followed by concurrent chemoradiotherapy with 6 cycles of nimotuzumab 200 mg and cisplatin 20 mg given weekly along with 60 gy/30 fractions of radiation using IMRT. Latest CT scan done on 20/01/2014 revealed no evidence of disease (NED).